¡Ya estamos en !
Descubre más
Allogene Therapeutics
1.31
USD
-0.03
2.24%
Al cierre
Actualizado
16 oct, 4:00 p.m. EDT
Antes de la apertura del mercado
Después del cierre del mercado
1.31
0.00
0%
1 día
-2.24%
5 días
-9.66%
1 mes
-22.49%
3 meses
-26.82%
6 meses
-44.73%
En lo que va del año
-2.96%
1 año
3.15%
5 años
-91.67%
10 años
-94.76%
Nuevas
Aumentadas
Mantenido
Reducidas
Cerradas
AUM masivo
Más de $200 mil millones
AUM elevado
De $10 mil millones a $200 mil millones
AUM medio
De $2B a $10B
AUM bajo
De $250M a $2B
AUM micro
Menos de $250M
Menos de 10%
Menos de 20%
Menos de 40%
Menos de 60%
Menos de 80%
| # | Nombre | Posición | Valor operado |
Cambio en acciones |
Cambio en la participación |
|
|---|---|---|---|---|---|---|
| 1 |
1
BlackRock
New York
| USD 62.7 M | +USD 24.3 M | +11,055,868 | +58% |
|
| 2 |
P
2
Pfizer
New York
| USD 46.9 M | – | – | – |
|
| 3 |
3
Frazier Life Sciences Management
Palo Alto,
California
| USD 46.7 M | +USD 41 M | +18,650,000 | +491% |
|
| 4 |
4
State Street
Boston,
Massachusetts
| USD 39.6 M | +USD 22.8 M | +10,365,520 | +120% |
|
| 5 |
5
TPG GP A
Fort Worth,
Texas
| USD 38.9 M | – | – | – |
|
| 6 |
6
Sio Capital Management
New York
| USD 27.7 M | +USD 29.3 M | +13,323,431 | Nuevas |
|
| 7 |
7
Primecap Management
Pasadena,
California
| USD 27.3 M | +USD 10.4 M | +4,743,600 | +57% |
|
| 8 |
8
Vanguard Capital Management
Malvern,
Pennsylvania
| USD 25.3 M | +USD 11.5 M | +5,245,286 | +76% |
|
| 9 |
9
Fidelity Investments
Boston,
Massachusetts
| USD 25 M | +USD 22.9 M | +10,419,213 | +655% |
|
| 10 |
10
Citadel Advisors
Miami,
Florida
| USD 21 M | +USD 7.23 M | +3,294,150 | +48% |
|
| 11 |
11
Two Sigma Investments
New York
| USD 16.2 M | +USD 5.29 M | +2,408,892 | +45% |
|
| 12 |
12
Geode Capital Management
Boston,
Massachusetts
| USD 14.7 M | +USD 6.42 M | +2,925,150 | +71% |
|
| 13 |
13
Goldman Sachs
New York
| USD 12.8 M | +USD 7.43 M | +3,382,715 | +122% |
|
| 14 |
GGI
14
GordonMD Global Investments
Beverely Hills,
California
| USD 11 M | +USD 8.49 M | +3,868,000 | +270% |
|
| 15 |
15
Marshall Wace
London,
United Kingdom
| USD 10.6 M | +USD 3.62 M | +1,647,424 | +48% |
|
| 16 |
16
Patient Square Capital
Menlo Park,
California
| USD 10.5 M | +USD 3.51 M | +1,600,000 | +46% |
|
| 17 |
17
Aberdeen Group
Edinburgh,
United Kingdom
| USD 10.4 M | +USD 7.77 M | +3,539,533 | +242% |
|
| 18 |
18
Millennium Management
New York
| USD 10.1 M | +USD 3.34 M | +1,521,836 | +46% |
|
| 19 |
19
D.E. Shaw & Co
New York
| USD 9.8 M | +USD 4.28 M | +1,946,959 | +70% |
|
| 20 |
20
T. Rowe Price Associates
Baltimore,
Maryland
| USD 9.7 M | -USD 1.63 M | -741,619 | -14% |
|
| 21 |
21
Morgan Stanley
New York
| USD 9.38 M | +USD 7.71 M | +3,511,117 | +352% |
|
| 22 |
22
Woodline Partners
San Francisco,
California
| USD 9.36 M | +USD 2.2 M | +999,546 | +29% |
|
| 23 |
23
Candriam SCA
Strassen, Luxembourg,
Luxembourg
| USD 9.01 M | +USD 2.94 M | +1,338,978 | +45% |
|
| 24 |
24
Vanguard Portfolio Management
Malvern,
Pennsylvania
| USD 8.76 M | +USD 5.53 M | +2,517,966 | +149% |
|
| 25 |
25
Renaissance Technologies
New York
| USD 7.98 M | +USD 3.72 M | +1,694,984 | +79% |
|